Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...
متن کاملIntravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
PURPOSE To report the change in visual acuity and central retinal thickness by optical coherence tomography (OCT) after intravitreal injections of bevacizumab for the treatment of neovascular age-related macular degeneration (AMD). METHODS A retrospective case series in a university-based practice evaluated patients with subfoveal choroidal neovascularization (CNV) due to AMD. Patients receiv...
متن کاملChoroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
An otherwise healthy 27-year-old woman presented with complaints of sudden painless blurred vision in the right eye for one week. On examination, visual acuity was 20/30 in the right eye and 20/20 in left eye. Fundus examination OS was normal, but OD demonstrated an elevated, opaque, yellowish parapapillary choroidal lesion with grayish membrane associated with minimal subretinal fluid, suggest...
متن کامل[Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type I].
CLINICAL CASE We report a case of a 42 year-old male with a macular edema due to idiopathic juxtafoveal retinal telangiectasis type i, treated with 3 sequential injections of intravitreal bevacizumab (1.25 mg in 0.05 ml). Anatomical improvements were observed after one year of follow up. DISCUSSION There is currently no general consensus regarding the treatment of unilateral idiopathic juxtaf...
متن کاملIntravitreal bevacizumab for peripapillary choroidal neovascular membranes.
nesh, Kaliki, and Shields) and Pediatric Ophthalmology and Ocular Genetics Services (Drs Ganesh and Levin), Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania. Correspondence: Dr Shields, Ocular Oncology Service, Wills Eye Institute, 840 Walnut St, Ste 1440, Philadelphia, PA 19107 ([email protected]). Author Contributions: Dr Shields had full access to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Eye
سال: 2007
ISSN: 0950-222X,1476-5454
DOI: 10.1038/sj.eye.6702946